Topical Infographics Canada

New Therapeutic Options
USA
Canada

Forecasting New Pharma Products – Improving accuracy

Physicians recognize that new medications often can be quite valuable for their patients and are eager to add them to their armamentarium. However, they do not always end up prescribing these new medications as much as they initially plan or as early as they would like. There are many reasons that can explain this discrepancy....

Branded-Vs-Generic-Medications
USA
Canada

Understanding Patient Influence on Disease Management and Treatment Options

Patients are an increasingly influential stakeholder within the healthcare industry as more medical information becomes available online than ever before. This independent market research study conducted by MD Analytics takes a closer look at patients in order to better understand their motivations and predict their behaviours within this complex landscape....

Social-Media-For-Physicans
USA
Canada

Physician Use of Social Media

Physicians are using social media in their personal and professional lives, especially younger physicians. However, the pharma industry should be aware of barriers to using social media as a means of interacting professionally with physicians, such as the perceived reliability of online information....

Channel-Egagement-For-Healthcare
USA
Canada

Customer Engagement in the Pharmaceutical Industry – Why channels of communication matter

Measuring customer engagement in pharmaceutical market research can be challenging as physicians usually prefer to not be seen as “associated” with any given pharmaceutical company. However, as demonstrated by our customer engagement syndicated study, it is undeniable that stronger levels of physician engagement exist among pharmaceutical companies which can lead to more positive outcomes for their associated brands....

RCT-vs-RWE
USA
Canada

Real World Evidence – Does it influence prescribing decisions?

Real World Evidence (RWE) is a growing area of research that, pivoting from the rigorously controlled standards of randomized controlled trials (RCT), is based on a model driven by real world patient data. Real World Evidence stems primarily from an observational analysis of a sample in a less controlled environment. Focused on the efficacy and outcomes of therapies in a real world setting, RWE provides a unique lens not attainable from traditional clinical trial research....

Barriers-Physicians-Face
USA
Canada

Physicians’ Perspectives on Pitfalls in the Patient Journey

In the healthcare system, a patient’s journey to optimal care presents many obstacles. There are numerous steps involved from the onset of a medical condition to the moment when satisfactory results are achieved. This healthcare survey seeks to reveal key opportunities within the patient journey that would assist patients along their way and ultimately improve outcomes. Further healthcare market research could also be conducted by disease area to dig deeper into these insights....

Canadian-Healthcare
USA
Canada

Are Canadians Taking Unnecessary Risks with Their Health?

Over a 3-day period, MD Analytics surveyed 1,000 Canadians that are responsible for making health-related decisions. It was found that respondents are often choosing to not to see a physician when health-related scenarios arise, citing self-diagnosis or lack of convenience as their key reasons. Respondents are also strongly likely to visit a walk-in clinic instead of their family physician, with convenience again mentioned as the key reason....

Medical-Qualitative-Research
USA
Canada

A Guide to Successful Qualitative Research

Qualitative research can provide a greater understanding of physicians’ attitudes and behaviours than quantitative methodologies, however increased demands on physician time may cause some to refuse participating. Determining the optimal study design and appropriate recruitment techniques can help make physicians more willing to participate....

Biosimilar-Use-In-Cancer-Treatment
USA
Canada

Biosimilar Use in Cancer Treatment – Current attitudes and perceptions

Biological drugs, protein-based products derived from living cells using biotechnology, have been used since the 1990’s as a treatment option for cancer patients. Since 2009, biosimilar therapies (therapeutically equivalent subsequent entry biologics) have been available in different therapeutic areas in Canada, and are now on the verge of becoming available for use in oncology....

Recreational-Cannabis-Legalization
USA
Canada

Recreational Cannabis’ Impact on Physicians’ Practice

The Canadian Senate recently passed Bill C-46 which will allow for the legal use of recreational cannabis across Canada by Fall 2018. While some physicians anticipate this new legislation will impact their practices with patients electing to try recreational cannabis instead of more traditional prescription medications or medical cannabis, others anticipate increases in patient visits related to dependence and psychotic symptoms....

CTA

We are here to answer your questions.

Ready to explore how data-driven insights can accelerate your pharmaceutical research? Connect with our team to discuss your goals.